StockNews.com has reduced its rating on Addus HomeCare (NASDAQ:ADUS).
Stock analysts Bloomberg lowered their recommendation for Addus HomeCare (NASDAQ:ADUS) from a “strong buy” rating to a “buy” rating in a note sent to investors on Saturday. The note was sent to investors by e-mail. In recent times, ADUS has been discussed with many other brokerages. In a research note published on Wednesday, August 3, Oppenheimer reduced his price target on Addus HomeCare shares from $135.00 to $130.00. Despite this change, the investment bank retained its “outperforming” rating on the company. On June 28, Stifel Nicolaus published a research note in which Addus HomeCare was discussed at length as a potential investment opportunity.
They suggested investing in the company by buying shares and setting a price target of $101.00 per share. In a study released Aug. 3, Royal Bank of Canada lowered both its “outperform” rating and its target price for Addus HomeCare, which had previously been set at $111.00. The new target price is $110.00. Finally, in a research report published on Tuesday, June 21, Stephens lowered the target price he had set for Addus HomeCare’s stock price from $110.00 to $101.00 while maintaining his “overweight” rating on the company. . According to information provided by MarketBeat, six analysts have suggested investors buy shares in the company. The stock currently receives an average recommendation of “buy” and the price target, as determined by public consensus, is set at $110.40.
Addus HomeCare stock price and recent performance On Friday, NASDAQ:ADUS shares began trading at a price of $96.23 per unit. The three ratios, including the current ratio, the quick ratio, and the debt ratio, add up to a value of 2.0. The debt to equity ratio is now 0.33. The company’s market capitalization currently sits at $1.55 billion and has a price-to-earnings ratio of 34.87, a price-to-earnings growth ratio of 2.51, and a beta value of 0.85. The previous 50-day moving averages stand at $88.59 for the company, while the past 200-day moving averages stand at $84.43. The lowest point for Addus HomeCare over the past year was $68.57, while the highest point for the company last year was $108.11. On August 1, the latest quarterly report from Addus HomeCare, which trades on NASDAQ under the symbol ADUS, was released to the general public.
Quarterly earnings of $0.91 per share were announced by the company, which was ($0.01) lower than the average estimate of $0.92 per share among financial analysts. The company’s sales for the prior quarter reached a more than satisfactory $236.94 million, which compares favorably to the average projection of $238.40 million. Addus HomeCare’s return on equity was 8.63%, while the company’s net margin was 4.9%. During the third quarter, Addus HomeCare experienced an increase in revenue of 8.7% on an annual basis. The results for the same quarter of the previous year show that the company achieved earnings per share of $0.78, which is an increase over the performance of the previous year. Earnings per share for the current fiscal year at Addus HomeCare are expected to be $3.18, analysts working on the sell side of the investment industry said. Addus HomeCare Participate in Insider Buying and Selling Additionally, on August 15, Addus HomeCare Director Esteban Lopez sold 1,100 shares of the company.
The sale of the shares at an average price of $95.00 per share generated total revenue of $104,500.00 for the company. The price of each individual share was $95.00. The administrator now owns 2,064 company shares, which have a total value of $196,080 as a result of the successful transaction. Notification of the transaction has been submitted to the Securities and Exchange Commission in the form of a filing; the file in its entirety can be consulted by clicking on this link. The SEC has been notified of the transaction. On Friday, July 15, David W. Tucker, Executive Vice President of the company, sold 2,080 shares of the company, which is another remarkable event to note. This sum was acquired by purchasing a total of 1,872 shares at an average price of $90.00 each, resulting in the transaction of shares with a total value of $187,200.00.
Following the completion of the transaction, the executive vice president acquired direct ownership of 8,468 shares of the company, which together are worth a total of $762,120. If you click on this link, you will be redirected to the SEC filing where the sale was mentioned, so be sure to do so. The director, Esteban Lopez, also sold 1,100 shares of the company on Monday August 15. The shares were sold for a total value of $104,500.00 with an average price of $95.00 per share. This resulted in revenue of $104,500.00 from the sale of the shares. As a result of the transaction, the administrator now owns a total of 2,064 shares of the company which together are worth $196,080 according to the current market. Disclosures related to the sale can be found in this section of the website. As of the most recent trade date, insiders had sold 31,013 shares of the company in the past ninety days, raising a total of $2,898,765 in proceeds from the sale of those shares.
The personal accounts of company insiders hold a total of 4.50% of the total outstanding shares of the company. Institutional Driven Transactions Regarding Addus HomeCare Over the past few months, ADUS shares have been actively bought and sold by a number of institutional investors, including hedge funds and other types of institutional investors. During the period ending the fourth, Okabena Investment Services Inc. purchased shares of Addus HomeCare with a total value of $31,000. During the second quarter, Assetmark Inc. increased the amount of Addus HomeCare shares it held by 110.1%, bringing the total to 100%. Assetmark Inc. now owns a total of 374 shares of the company, which are currently valued at $31,000 after purchasing an additional 196 shares of the company during the quarter for a total of 196 shares purchased during the quarter. A brand new investment of $41,000 has been made in Addus HomeCare by Point72 Hong Kong Ltd. during the second quarter of 2018.
A new investment in Addus HomeCare stock, worth approximately $72,000, was made by Financial Management Professionals Inc. during the first quarter of 2018. Last but not least, during the second quarter, Heritage Wealth Management LLC made an investment of approximately $76,000 in Addus HomeCare. This is surely not the least of their achievements. A total of 96.04% of the company’s shares are collectively held by hedge funds and other types of institutional investors. In the United States, the elderly, chronically ill, disabled, and others at risk of hospitalization or institutionalization may obtain personal care services from Addus HomeCare Corporation and its affiliates.
These services are offered to anyone at risk of being hospitalized or institutionalized. The Addus HomeCare Corporation provides these various services to its customers. Personal care, palliative care, and home health care are the three main areas that this organization focuses on in terms of operation.